
Loading, please wait...

Loading, please wait...

For clinicians managing patients at risk for autoimmune diabetes, understanding the nuances of glycemic markers is critical for predicting Type 1 Diabetes progression risk. However, recent research suggests that the standard HbA1c threshold of 5.7% may not be the most reliable indicator for adults. This is because HbA1c naturally increases with age due to non-glycemic factors. Consequently, using a universal cutoff often leads to an overestimation of risk in older populations. Therefore, researchers evaluated whether adjusting these thresholds based on age could provide a clearer clinical picture.
The study analyzed data from over 5,000 autoantibody-positive relatives participating in the TrialNet Pathway to Prevention study. Initially, when using the standard 5.7% threshold, children appeared to have a significantly higher one-year progression risk than adults. Specifically, children with multiple autoantibodies showed a 55% risk, while adults showed only 38%. However, these discrepancies largely disappeared when the research team applied age-adjusted HbA1c models. By accounting for physiological aging, the risk profiles between children and adults became comparable.
The research highlights that adults over the age of 30 naturally exhibit higher baseline HbA1c levels. Therefore, a higher threshold of 6.0% (42 mmol/mol) serves as a more pragmatic and accurate marker for this demographic. Furthermore, adopting this higher cutoff allows clinicians to better align adult risk stratification with established pediatric benchmarks. This shift is essential for avoiding unnecessary interventions and reducing patient anxiety in clinical practice.
In contrast, the study found that adults under 30 years of age demonstrated a progression risk profile very similar to that of children. For this younger adult cohort, the standard 5.7% threshold remains highly effective. Consequently, these findings advocate for a more nuanced, age-specific approach to monitoring individuals with islet autoantibodies. By refining these diagnostic thresholds, healthcare providers can ensure that the highest-risk individuals receive timely follow-up and appropriate therapy initiation.
HbA1c levels naturally increase with age even in individuals with normal glucose tolerance. Because the standard 5.7% threshold does not account for this physiological drift, it may incorrectly flag older adults as being at high risk for rapid progression.
The research suggests that a threshold of 6.0% (42 mmol/mol) is more accurate for adults aged 30 and older. This higher cutoff ensures that the Type 1 Diabetes progression risk is quantified similarly across different age groups.
Yes. Data indicates that adults under the age of 30 have a progression risk profile similar to that of children. For this younger population, the standard 5.7% threshold remains a reliable predictor of dysglycemia and future diabetes risk.
Disclaimer: This content is for informational and educational purposes only and does not constitute professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Templeman EL et al. Accounting for Age-Related Increases in HbA1c More Accurately Quantifies Risk of Type 1 Diabetes Progression in Islet Autoantibody-Positive Adults. Diabetes Care. 2026 May 06. doi: undefined. PMID: 42090204.
Dubowitz N, Xue W, Long Q, et al. Aging is associated with increased HbA1c levels, independently of glucose levels and insulin resistance, and also with decreased HbA1c diagnostic specificity. Diabet Med. 2014;31(8):927-935.
TrialNet Pathway to Prevention of T1D | Clinical Research Studies Listing. All IN for Health. Accessed May 2026.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A study suggests that age-adjusted HbA1c or a higher threshold of 6.0% more accurately predicts Type 1 Diabetes progression risk in adults over 30....
4 months ago

A new study reveals that lipid-related metabolic dysregulation, marked by elevated TG/HDL-C ratio and glymphatic changes, independently impacts survival in idiopathic normal pressure hydrocephalus.
Today

A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today

A meta-analysis of 13 propensity score-matched studies shows ViV-TAVR delivers lower early mortality and reduced bleeding compared to redo-SAVR for degenerated bioprosthetic aortic valves, though long-term hemodynamics warrant careful anatomical and patient-centered evaluation.
Today

Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday

The All-India Food Processors' Association has approached the Supreme Court to oppose FSSAI's proposed per-100g benchmark for front-of-pack warning labels, advocating instead for a per-serving threshold. We explore the regulatory showdown, nutritional evidence, and implications for clinical lifestyle counseling.
Today